Edwards Lifesciences (EW) Current Leases (2014 - 2026)

Edwards Lifesciences' Current Leases history runs 9 years deep, the most recent figure standing at $24.3 million for Q1 2026.

• In Q1 2026, Current Leases rose 2.53% year-over-year to $24.3 million; the TTM figure through Mar 2026 stood at $24.3 million (up 2.53% YoY), while the FY2025 annual figure was $24.5 million, up 4.7% from the prior year.
• Current Leases was $24.3 million for Q1 2026 at Edwards Lifesciences, down from $24.5 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $26.8 million in Q3 2025 to a low of $21.5 million in Q2 2024.
• Historically, Current Leases has averaged $24.2 million across 5 years, with a median of $24.3 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Leases retreated 11.52% in 2024, then gained 20.47% in 2025.
• A 5-year view of Current Leases shows it stood at $25.5 million in 2022, then decreased by 10.2% to $22.9 million in 2023, then grew by 2.18% to $23.4 million in 2024, then increased by 4.7% to $24.5 million in 2025, then declined by 0.82% to $24.3 million in 2026.
• The last three Current Leases figures came in at $24.3 million (Q1 2026), $24.5 million (Q4 2025), and $26.8 million (Q3 2025), per Business Quant data.